Richard Wagner
Vorstandsvorsitzender bei Bonito Biosciences
Vermögen: - $ am 30.04.2024
Profil
Richard W.
Wagner was the founder of X-Chem, Inc. (Massachusetts) founded in 2009, Zebiai Therapeutics, Inc. founded in 2019, and Bonito Biosciences founded in 2022, where he held the title of Chief Executive Officer.
He also held the position of Executive Vice President-Discovery Research at Praecis Pharmaceuticals, Inc. and served as an Independent Director at Eterna Therapeutics, Inc. for the year 2023.
Dr. Wagner holds a doctorate degree from Brown University and an undergraduate degree from Trinity College (Connecticut).
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
ETERNA THERAPEUTICS INC.
-.--% | 13.07.2023 | 0 ( -.--% ) | - $ | 30.04.2024 |
Aktive Positionen von Richard Wagner
Unternehmen | Position | Beginn |
---|---|---|
Bonito Biosciences | Vorstandsvorsitzender | 01.06.2022 |
Ehemalige bekannte Positionen von Richard Wagner
Unternehmen | Position | Ende |
---|---|---|
ETERNA THERAPEUTICS INC. | Direktor/Vorstandsmitglied | 08.08.2023 |
X-Chem, Inc. (Massachusetts)
X-Chem, Inc. (Massachusetts) Packaged SoftwareTechnology Services X-Chem, Inc. operates as a biotechnology company. Its uses its DEX DNA encoded libraries and platform to discover small molecule leads against high-value therapeutic targets. The company was founded by Richard W. Wagner, Brant C. Binder, Matthew A. Clark, and Gordon M. Binder in 2009 and is headquartered in Waltham, MA. | Vorstandsvorsitzender | 03.06.2020 |
Zebiai Therapeutics, Inc.
Zebiai Therapeutics, Inc. Packaged SoftwareTechnology Services Zebiai Therapeutics, Inc. develops artificial intelligence to predict and optimize novel small molecule modulators for challenging drug targets. The company was founded by Richard Wagner and is headquartered in Chestnut Hill, MA. | Vorstandsvorsitzender | - |
Praecis Pharmaceuticals, Inc.
Praecis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Praecis Pharmaceuticals, Inc. develops drugs and therapies for the treatment of cancer. The firm also develops peptide-based drugs. The company was founded 1993 and is headquartered in Waltham, MA. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Richard Wagner
Brown University | Doctorate Degree |
Trinity College (Connecticut) | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
ETERNA THERAPEUTICS INC. | Health Technology |
Private Unternehmen | 4 |
---|---|
Praecis Pharmaceuticals, Inc.
Praecis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Praecis Pharmaceuticals, Inc. develops drugs and therapies for the treatment of cancer. The firm also develops peptide-based drugs. The company was founded 1993 and is headquartered in Waltham, MA. | Health Technology |
X-Chem, Inc. (Massachusetts)
X-Chem, Inc. (Massachusetts) Packaged SoftwareTechnology Services X-Chem, Inc. operates as a biotechnology company. Its uses its DEX DNA encoded libraries and platform to discover small molecule leads against high-value therapeutic targets. The company was founded by Richard W. Wagner, Brant C. Binder, Matthew A. Clark, and Gordon M. Binder in 2009 and is headquartered in Waltham, MA. | Technology Services |
Zebiai Therapeutics, Inc.
Zebiai Therapeutics, Inc. Packaged SoftwareTechnology Services Zebiai Therapeutics, Inc. develops artificial intelligence to predict and optimize novel small molecule modulators for challenging drug targets. The company was founded by Richard Wagner and is headquartered in Chestnut Hill, MA. | Technology Services |
Bonito Biosciences |